Macular Degeneration Foundation

AAO 2022: Divya Parthasarathy Rao MD

Divya Parthasarathy Rao MD Presentation: Deep-learning automated screening tool for AMD Remidio Innovative Solutions Inchttp://www.remidio.com

AAO 2022: Yannis Paulus MD

Presentation: Clinical Validation of a Handheld Device forRemote Monitoring of Dry Macular Degeneration Yannis Paulus MD University of Michigan, Kellogg Eye Centerypaulus@med.umich.eduYannis Paulus Labhttp://www.paulus.lab.medicine.umich.edu734-764-4182

AAO 2022: David Boyer MD

PRESENTATION: Apellis and GATHER1 Study Treatment ( Pegcetacoplan ) for Geographic Atrophy in Dry AMD Patients David Boyer MDUSC Keck School of Medicine

AAO 2022: Charles Wykoff MD, PhD

PRESENTATION: Derby & Oaks Trial for treatment of Dry AMD with Geographic Atrophy using Pegcetacoplan Charles Wykoff, MD, PhDRetina Consultants of Texas http://www.retinaconsultantstexas.com (800) 833-5921 Apellis gastudy.com

AAO 2022: Susanna Park MD, PhD

PRESENTATION: Status of current stem cell therapeutics and how to avoid bad trials. Susanna S Park MD, PhD – UC Davis sscpark@ucdavis.edu 800-2-UCDAVIS (800-282-3284) https://health.ucdavis.edu

AAO 2022: David Boyer MD

PRESENTATION: Lighthouse III Study Photomodulation Therapy for Dry Macular Degeneration David Boyer, MDUSC Keck School of Medicine

AAO 2022: Anat Loewenstein MD

PRESENTATION: Home Diagnostic Testing Anat Loewenstein MD, Tel-Aviv Medical Center. Home OCT (Optical Coherence Tomography) and other available home diagnostic testing.

AAO 2022: Joe Fontenot MD, CLVT

PRESENTATION: Charles Bonnet Syndrome Joe Fontenot, MD, CLVT Community Services for Vision Rehabilitationhttp://www.csvrlowvision.org251-476-4744 in Mobile251-928-2888 in Daphne251-721-1160 in Foley

AAO 2022: Mitul C Mehta MD

PRESENTATION: Adaptive smart glasses for low vision patients with visual scotoma. Mitul C Mehta MD, CEO – Eyedaptic.

AAO 2022: John Shepherd MD

PRESENTATION: Low Vision Resources and Services to Assist Patients John Shepherd, MD The Weigel Williamson Center for Visual RehabilitationUniversity of Nebraska Medical Center

AAO 2022: Carl Danzig MD

PRESENTATION: New Treatments for Dry AMD Carl Danzig, M.D. Rand Eye Institute Pampano Beach, FL (954) 782-1700http://www.randeye.com

AAO 2022: Tom Ruggia CEO

PRESENTATION: Telescopic Lens Implant Tom Ruggia, CEO Samsara Vision http://www.samsaravision.com (408) 872-9393 Samsara Vision SING IMT Telescopic Lens Implant Concerto Trial For clinical trial information: http://www.oraconnects.com

AAO 2022: Gilad Rabina MD

PRESENTATION: What happens if you miss treatment for more than a month? Gilad Rabina, MD – Tel Aviv Medical Center In nAMD patients, delayed care secondary to COVID-19 pandemic lockdowns has no significant impact on BCVA. Baseline BCVA and lower number of anti-VEGF injections are predictors for decreased visual acuity.

AAO 2022: Joe Fontenot MD

PRESENTATION: Low Vision Gadgets and Devices Joe Fontenot, MD, CLVT Community Services for Vision Rehabilitationhttp://www.csvrlowvision.org251-476-4744 in Mobile251-928-2888 in Daphne251-721-1160 in Foley

AAO 2019: Joe Fontenot MD CLVT

Joe Fontenot, MD, CLVT Medical Director Community Services for Vision Rehabilitation http://www.csvrlowvision.org MOBILE, AL 251-476-4744 DAPHNE, AL 251-928-2888 Presentation: New Technologies, approaches and techniques for low vision community

AAO 2019: Rahul Khurana MD

Rahul Khurana, MD Northern California Vitreous Associates http://www.ncrva.com Presentation: New treatment possibilities for Neovascular Macular Degeneration

AAO 2019: Charles Wykoff MD PhD

Charles Wykoff MD PhD Retinal Consultants of Houston http://www.houstonretina.com (713) 524-3434 Presentation: A Phase I/Ib Open Label, Multi-center Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With Wet Age-Related Macular Degeneration, Diabetic Macular Edema and …

AAO 2019: Franco M Recchia MD

Franco M Recchia MD Tennessee Retina (615) 983-6000 http://www.tnretina.com Presentation: Clinical Trial Outcomes and Real-World Patients

AAO 2019: Ronald Gentile MD

Ronald Gentile, MD, FACS, FASRSGentile RetinaRetina Surgeon at The New York Eye and Ear Infirmary of Mount Sinai (NYEE) http://www.gentileretina.com 1-212-979-4120 http://www.NYEE.edu Presentation: S.A.T.I.S.F.Y your patient

AAO 2019: Tom Perski

Tom Perski, VP Iris Vision Global Sales: (855) 449-4536 Support: (855) 207-6665 Irisvision.com Presentation: New features and accessibility available in wearable low vision devices designed for people with limited field of vision

AAO 2019: Shailesh Gupta MD

Shailesh Gupta MD Coral Springs/Boca Raton (561) 322-3588 http://specialtyretina.com Presentation: Comparative Evaluation Of Fonts In Electronic Tablet–Assisted Improvement Of Reading Ability As Well As Quality Of Life In Patients With Poor Vision Secondary To Macular Degeneration

AAO 2019: David S Boyer MD

David S Boyer MD Retina-Vitrieous Associates Medical Group Adjunct Clinical Professor at USC http://www.laretina.com Los Angeles, CA Phone: (213) 483-8810 Presentation: Early treatment for dry AMD Prophylaxis Intravitreal Aflibercept Injection Against Conversion to nAMD in High-Risk Eyes (PRO-CON): 24-Month Results

AAO 2019: Richard Rosen MD

Richard Rosen, MD at AAO 2019Icahn School of Medicine at Mount Sinai New York Eye and Ear Infirmary of Mt Sinaihttp://www.nyee.edu212-979-4288 Presentation: Metabolic Imaging Using Flavoprotein Autofluorescence

AAO 2019: Jakob Siedlecki MD

Jakob Siedlecki, MD Ludwig-Maximilians-University of Munich Presentation: Growth Rate of Primary Geographic Atrophy Complicated by Active CNV ( choroidal neovascularization ) in AMD

AAO 2019: Mitul Mehta MD

Mitul Mehta, MD UC Irvine EYEDAPTIC Presentation: Performance of an Augmented Reality Device on Functional Activities for people with AMD

AAO 2019: Philip Hessburg MD

Presentation: Nano Electronic Visual Prosthetic Devices Eye and the ChipDetroit Institute of Ophthalmology Henry Ford Health System 313-936-1968 Office rhorne1@hfhs.org Website: https://www.henryford.com/hcp

AAO 2019: Philip Hessburg MD

Philip Hessburg, MD Detroit institute of Ophthalmology Henry Ford Health System Presentation: What “blindness” means for AMD patients

AAO 2019: David A Eichenbaum MD

Presentation: Additional Anatomic Endpoints Support Sustained Outcomes With Faricimab Every 16 Weeks in the STAIRWAY Phase 2 Trial for neovascular AMD David A Eichenbaum MDRetina Vitreous Associates of FloridaSAINT PETERSBURG (727) 323-0077CLEARWATER (727) 445-9110TAMPA (813) 879-5795 https://retinavitreous.com

EYESIGHT 2019: Sarah Zhang MD

Sarah Zhang MD University at Buffalo Jacobs School of Medicine and Biomedical Sciences Presented research: Loss of XBP1 accelerates age-related decline in retinal function and neurodegeneration

EYESIGHT 2019: Sayon Roy PhD

Sayon Roy PhD FARVO Conference Chairman Professor of Medicine and Ophthalmology Boston University School of Medicine About USG EYE 2019 Meeting Presented research: Vascular Basement Membrane Thickening in Diabetic Retinopathy

Select any channel below to view all posts within that channel: